Abstract

To evaluate the effect of hyperin in cisplatin-induced liver injury in mice. Mice were pretreated with hyperin at doses of 25 mg/kg and 50 mg/kg, respectively, for six days, and intraperitoneal injection of cisplatin (40 mg/kg) was administrated one hour after the final intragastrication of hyperin. Twenty-four hours later, blood and liver were collected for further research. A single injection of cisplatin (40 mg/kg) for 24 h significantly increased serum alanine and aspartate aminotransferases (ALT/AST) and gamma glutamyl transferase (GGT) activities, whileas hyperin reversed cisplatin-induced such increases. Liver histopathological examination further demonstrated the protection of hyperin against cisplatin-induced liver injury. Further results showed hyperin reversed cisplatin-induced the increase in content of malondialdehyde (MDA) and the decrease in level of total antioxidant capacity (T-AOC) in liver. Moreover, hyperin increased the levels of superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), glutathione peroxidase (GPx), glutathione-s transferase (GST) in cisplatin-induced liver. Hyperin inhibits cisplatin-induced hepatic oxidative stress, which contributes greatly to the amelioration of cisplatin-induced liver injury in mice.

Highlights

  • IntroductionIn spite of the benefits available, it is accompanied with potent side effects

  • Chemotherapy plays an important role in the treatment of cancer nowadays

  • The dose selection was based on the literatures[16,20,21] and our preliminary experiment. 24 hours later, blood samples were collected by extirpating the eyeball, approximately 0.8 ml per mice, and mice were sacrificed, their livers were removed for further research

Read more

Summary

Introduction

In spite of the benefits available, it is accompanied with potent side effects. The severe reactions of chemotherapeutic agents are a major limitation to the use of drug in the clinic[1]. Cisplatin is a potent chemotherapeutic agent used for the treatment of a wide range of cancer such as ovarian, cervical, and head and neck cancers[2,3]. Cisplatin therapy brings about undesirable side effects, including renal dysfunction[4], ototoxicity[5], nausea and vomiting[6], and hepatotoxicity[7]. Hepatotoxicity is not considered to be a dose limiting toxicity for cisplatin, but liver toxicity can occur when it is administered at high doses[8], which has been an obstacle for the further usage of cisplatin

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.